February 17, 2026

FDA Broadens Pitolisant Label

The US Food and Drug Administration approves pitolisant (WAKIX) tablets for the treatment of cataplexy in pediatric patients aged 6 years and older with narcolepsy.

Conexiant

February 13, 2026

What Was Promised at Confirmation?

After pledging to uphold vaccine policy and funding, RFK Jr. has reshaped advisory panels, research priorities, and immunization guidance.

KFF Health News

February 11, 2026

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Conexiant

February 10, 2026

Why Scientists Are Revisiting a Polarizer

The nation’s top cancer institute takes a closer look at a disputed drug.

KFF Health News

February 09, 2026

The Assignment Some Doctors Refused

Forced deployments to immigration detention are pushing US public health clinicians to resign—and raising urgent questions about medical ethics, obedience, and harm.

KFF Health News

January 30, 2026

Hospitals, Custody, and the Missing Patient

As detained patients enter hospitals, access to care, communication, and advocacy becomes unclear.

KFF Health News

January 28, 2026

When Crisis Calls Go Unanswered

Behind the promise of 988, response breakdowns reveal risks for patients in acute distress.

KFF Health News

January 27, 2026

The Exam Room Is Listening Now

As AI quietly enters exam rooms, physicians report real relief—and real concerns about accuracy, trust, and control.

KFF Health News

January 27, 2026

CDC Database Pauses Raise Concerns

Researchers review the scope and characteristics of unexplained pauses in CDC surveillance databases and examine potential implications for public health monitoring.

Conexiant